70 articles on glp-1 basics in Weight Loss.
AOD-9604 is the 177-191 fragment of human growth hormone. What the rodent studies measured, why the obesity program stopped, why there is no published human efficacy trial, and where it sits with FDA today.
AOD-9604 is a fragment of human growth hormone (residues 177-191). What the rodent studies measured, why there are no published human trial results, the doses that appear in the research, WADA status, and where it sits under FDA compounding rules.
The compound semaglutide ban is tied to FDA shortage status, not a permanent prohibition. Here is what the rules actually say, what changed, and what patients should do now.
Why clinicians compound semaglutide with B12 and pyridoxine, what each ingredient contributes, and what to ask your prescriber about this combination formulation.
Confused about whether compound tirzepatide is banned? Here is what the FDA shortage-period ruling actually said, what changed in 2025, and what access looks like now.
Is compounded tirzepatide going away? Here is what the FDA shortage status, court rulings, and 503A compounding rules actually mean for patients considering compounded tirzepatide today.
Many compounded tirzepatide formulations include vitamin B12. This guide explains why B12 is added, what the evidence says, and what to ask your clinician before starting.
Does GLP-1 pills work? One FDA-approved oral GLP-1 pill (Rybelsus) does work — but OTC GLP-1 supplements do not contain the active ingredient. We break down the difference and what your options are.
FDA-approved GLP-1 drugs include semaglutide and tirzepatide for weight management, plus several others for type 2 diabetes. This guide explains the mechanism, approved indications, and how compounded GLP-1 options fit within that landscape.
The complete GLP-1 agonist medications list — semaglutide, tirzepatide, liraglutide, dulaglutide, exenatide, and others — with mechanism, dosing route, and how each fits into weight management and metabolic care.
GLP-1 receptor agonists are under active investigation for Alzheimer's and cognitive decline. Here's what the current evidence shows, what remains uncertain, and how this intersects with clinician-supervised weight management.
Does GLP-1 help with inflammation? Research suggests GLP-1 receptor agonists may reduce systemic inflammatory markers beyond weight loss. Here\'s what the evidence actually says.
A complete list of GLP-1 names — receptor agonist drugs, their generic names, brand names, and what each one does — so you can compare options with a clinician.
A complete GLP-1 drug list covering every approved receptor agonist, how each mechanism differs, which are available for weight management, and what the compounded options are.
GLP-1 for men — how compounded semaglutide and tirzepatide affect weight, muscle composition, testosterone, and metabolic health, and how clinician-prescribed protocols differ from DIY approaches.
The GLP-1 gila monster connection explained — how a compound in Heloderma suspectum saliva led to the first GLP-1 drug and eventually to semaglutide and tirzepatide. The actual science behind the discovery.
A complete list of GLP-1 medications — FDA-approved branded drugs, compounded injectables, and the differences that matter for patients exploring clinician-supervised weight management.
A complete list of GLP-1 oral drugs approved or in late-stage development. Understand how oral GLP-1 receptor agonists differ from injectables, what to expect, and how to access clinician-supervised GLP-1 therapy.
A clinician-grounded guide to GLP-1 oral medications — how they work, how oral bioavailability compares to injectable formulations, and what the research shows for adults pursuing prescription weight management.
GLP-1 pill (oral semaglutide) vs injectable: how absorption differs, what the dosing looks like, who each format suits, and how compounded injectables compare to brand-name options.
GLP-1 tablet options versus injectable GLP-1 agonists — a research-grounded comparison covering bioavailability, clinical evidence, dosing requirements, and what to consider when discussing options with a clinician.
A balanced look at the pros and cons of GLP-1 receptor agonists — what the clinical evidence shows about weight management benefits, the side effects to expect, and who makes a good candidate.
What is a GLP-1 receptor agonist? This guide explains the GLP-1 pathway, how receptor agonists mimic incretin action, the mechanisms behind appetite and weight effects, and how compounded semaglutide and tirzepatide fit in.
A complete GLP-1 receptor agonist list covering every FDA-approved drug and compounded peptide option, how they compare, and how clinician-prescribed compounded semaglutide fits the picture.
What is GLP-1 medication? A plain-language explanation of how GLP-1 receptor agonists work, the difference between natural GLP-1 and prescription medications, and what clinician-supervised GLP-1 therapy involves.
How do GLP-1 drugs work? This guide explains the GLP-1 receptor agonist mechanism — gut-to-brain signaling, appetite regulation, gastric emptying, and how compounded semaglutide and tirzepatide fit into that picture.
How does tirzepatide work for weight loss? It activates both GIP and GLP-1 receptors — a dual mechanism that reduces appetite, slows digestion, and improves metabolic signaling. Here\'s the biology.
How does GLP-1 help you lose weight? It works through appetite suppression, slowed gastric emptying, and improved satiety signaling — not willpower. Here is the full mechanism.
How long does GLP-1 stay in your system? This guide covers the half-lives of compounded semaglutide and tirzepatide, what happens when you stop, and why duration matters for dosing.
Semaglutide has a half-life of approximately 7 days, meaning it stays in your system for roughly 5 weeks after the last dose. Here is what that means clinically.
How long does tirzepatide stay in your system? The half-life is approximately 5 days, meaning clearance takes 4–5 weeks. Here\'s what that means for dosing, side effects, and stopping the medication.
Is GLP-1 the same as Ozempic? No — GLP-1 is a hormone class, Ozempic is a brand name. This article explains the difference between the hormone, the drug class, and the branded products.
Is metformin a GLP-1? No. Metformin is a biguanide that works through AMPK and hepatic glucose pathways — a fundamentally different mechanism from GLP-1 receptor agonists like semaglutide or tirzepatide. This article explains the distinction clearly.
Lipo-C (MIC + B12) injections explained: what is in the shot, what each ingredient does, what the trials actually show, weekly dosing, side effects, and what it costs in 2026.
A factual guide to the newest GLP-1 medications available in 2026 — branded approvals, compounded options, dual agonists, and how to access them through a licensed clinician.
Oral semaglutide for weight loss: how the tablet compares to the injection, what clinical trials found on dose and outcomes, and when compounded injectable semaglutide fits a clinician-supervised weight management plan.
A guide to peptide injection for weight loss — which peptides have the strongest clinical evidence, how they work, what clinician supervision requires, and how to evaluate your options safely.
A clinician-informed guide to peptide therapy for weight loss — GLP-1 peptides with strong evidence, supporting peptides with limited data, and how to navigate the regulatory tiers before choosing a protocol.
The published retatrutide half-life, approximately 6 days from the phase 1b trial, compared against semaglutide and tirzepatide, with the steady-state arithmetic, the missed-week math, and the washout picture.
The retatrutide doses used in human trials, what the phase 2 and phase 3 results reported, what the published record says about side effects, and why an investigational triple agonist has no price.
A clinician-grounded look at the documented semaglutide benefits — weight management, metabolic markers, cardiovascular outcomes — and what they mean in a compounded, 503A-pharmacy context.
Semaglutide FDA approval covers branded prescription drugs for type 2 diabetes and obesity — not compounded semaglutide. Here is what that distinction means for patients exploring weight management options through a telehealth clinician.
Semaglutide for fat loss works by reducing appetite signals and slowing gastric emptying. Learn how the mechanism operates, what the clinical evidence shows, and how a clinician-supervised compounded protocol is structured.
Semaglutide was originally developed for type 2 diabetes management. This article explains the mechanism, how compounded semaglutide differs from branded drugs, and who a clinician-supervised weight management program may be appropriate for.
Semaglutide generic names, brand names, and what the INN tells you. Understand the difference between Ozempic, Wegovy, and compounded semaglutide — and why the active molecule is the same.
Semaglutide glycine B12 is a common compounded formulation. Learn what each ingredient does, why it\'s included, and what to ask your prescribing clinician about the formula.
Semaglutide with glycine is the standard compounded form of the peptide used in GLP-1 weight management protocols. Learn what glycine does, why it\'s there, and how 503A compounding works.
Semaglutide's half-life is approximately 1 week — which is why once-weekly dosing maintains steady plasma levels. Here's how that pharmacokinetics affects dosing timing, missed doses, and what happens when you stop.
Semaglutide patches sold online are not prescription GLP-1 medication. Semaglutide is a large peptide that cannot cross intact skin — transdermal delivery is not how this drug works. Here\'s what the evidence shows.
What the research says about semaglutide, GLP-1 receptor agonism, the STEP and SUSTAIN clinical trials, side effects, and how compounded semaglutide differs from Ozempic/Wegovy.
Comparing sublingual semaglutide and injectable semaglutide: bioavailability, dosing, regulatory status, and how clinicians choose between delivery routes for weight management.
Sublingual tirzepatide is an oral-dissolve formulation compounded by some 503A pharmacies. This guide covers the mechanism, absorption differences from injectable, and what to ask a clinician before choosing a delivery route.
Tesofensine is a triple monoamine reuptake inhibitor investigated for weight management — not a peptide, despite frequent misclassification. This guide covers the mechanism, clinical trial data, regulatory status, and how it compares to GLP-1 receptor agonists.
Tirzepatide for inflammation: how the GIP/GLP-1 dual agonist affects inflammatory markers, what preclinical and clinical data show, and why this matters beyond weight management.
Tirzepatide benefits include weight management, improved insulin sensitivity, and cardiovascular risk factor reduction. This guide covers the dual GIP/GLP-1 mechanism, what SURMOUNT and SURPASS trials found, and what a clinician evaluates before prescribing.
Tirzepatide cyanocobalamin compounds pair the dual GIP/GLP-1 agonist with vitamin B12 in a single injection. Learn why compounding pharmacies add cyanocobalamin, what the research says, and how clinician-supervised protocols are structured.
Does tirzepatide burn fat directly, or does it work differently? This article explains the dual GIP/GLP-1 mechanism behind tirzepatide\'s effect on body fat, appetite, and energy balance — and what the clinical evidence actually shows.
Tirzepatide for sleep apnea is now backed by a landmark randomized trial. This guide covers the SURMOUNT-OSA data, the proposed mechanism, what it means for patients, and how to access clinician-prescribed tirzepatide.
Tirzepatide is the generic (INN) name of the dual GIP/GLP-1 receptor agonist marketed as Mounjaro and Zepbound. This guide explains what the name tells you about the molecule and how compounded tirzepatide fits in.
Tirzepatide has an elimination half-life of approximately five days, which is why once-weekly injections maintain steady-state plasma levels. This guide explains what that means for dosing, timing, and the titration schedule.
Why tirzepatide methylcobalamin combinations are common in compounded formulations — what methylcobalamin is, why it is added, and what to ask your clinician.
Tirzepatide tablet vs injection: what the research shows about oral vs subcutaneous administration, how bioavailability and dosing differ, and what is available through licensed compounding today.
Does tirzepatide come in a pill form? This FAQ covers the current state of oral tirzepatide development, how injectable tirzepatide works, and what options are available today under clinician supervision.
Does tirzepatide come in pill form? This page explains the current approved and compounded forms of tirzepatide, why the injection remains the standard route, and what to expect from a clinician-supervised protocol.
What the research says about tirzepatide, dual GIP/GLP-1 receptor agonism, the SURMOUNT and SURPASS clinical trials, side effects, and how compounded tirzepatide differs from Mounjaro/Zepbound.
How does tirzepatide help sleep apnea? Research shows significant reductions in AHI events through fat-mass reduction and upper-airway anatomy changes. Here is what the data shows.
Tirzepatide with B12 is a common compounded formulation. Here's what vitamin B12 is added for, what the evidence says, and what to ask your prescriber.
Many compounded tirzepatide formulations include glycine and vitamin B12. This guide explains why those excipients are used, what evidence supports their inclusion, and what questions to ask your clinician.
What is compound tirzepatide? How it differs from branded Zepbound/Mounjaro, how 503A pharmacy compounding works, what the clinical evidence shows, and how a clinician-supervised protocol is structured.
Compounded semaglutide explained: what it is, how it differs from FDA-approved branded products, who can prescribe it, which pharmacies can fill it, and what the FDA shortage rules mean for patients.
Ready when you are
Take a 3-minute assessment and a licensed clinician will recommend the right protocol for you — compounded in the USA by licensed 503A pharmacies.